Publication | Open Access
Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival
32
Citations
34
References
2021
Year
The findings support the putative role of CDKN2B-AS1 as an epigenetic marker in BC and open a new avenue for its potential use as a therapeutic molecular target in this type of cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1